Abstract
Fil: Ripoll, Giselle Vanina. Universidad Nacional de Quilmes. Departamento de Ciencia y Tecnologia. Laboratorio de Oncologia Molecular; Argentina. Consejo Nacional de Investigaciones Cientificas y Tecnicas; Argentina
Highlights
Specialty section: This article was submitted to Molecular and Cellular Oncology, a section of the journal Frontiers in Oncology
A Commentary on Arginine vasopressin receptor 1a is a therapeutic target for castration-resistant prostate cancer by Zhao, N., Peacock, S
We completely agree with the authors in the sense that a>] identified the vasopressin receptor 1a (AVPR1a) can be a potential target for castration-resistant prostate cancer (CRPC) therapy
Summary
Specialty section: This article was submitted to Molecular and Cellular Oncology, a section of the journal Frontiers in Oncology. A Commentary on Arginine vasopressin receptor 1a is a therapeutic target for castration-resistant prostate cancer by Zhao, N., Peacock, S. Dissection of such mechanisms can lead to the identification of novel vulnerabilities of aggressive tumor cells that can be targeted therapeutically.
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
